Cambridge Antibody Technologies, Inc.

Description

Cambridge, U.K.; acquired by AstraZeneca for $13 billion in mid-2006

Related product monographs:

[custom_products_with_organization]

Location

Cambridge UK FOR

Reference Number

9521